Jilian A Sacks

Datos Biográficos

ID9067680
NOMBREJilian A Sacks
NOMBRESJilian A
APELLIDOSacks
FIRMASACKS J A
AFILIACIONESFIND
ORCID0000-0003-4815-4693
VERIFICADOSí
TOTAL DE OBRAS5
TOTAL DE CITAS0
TOTAL COMO AUTOR5
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2022
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0

  • Covid-19 self-testing

    Open AccessMelody Sakala, Cheryl Johnson et al.ARTICLEPLOS Global Public Health2024

    The widespread use of antigen-detection rapid diagnostic tests (Ag-RDTs) has revolutionized SARS-CoV-2 (COVID-19) testing, particularly through the option of self-testing. The full extent of Ag-RDT utilization for self-testing, however, remains largely unexplored. To inform the development of WHO guidance on COVID-19 self-testing, we conducted a global consultation to gather the views and experiences of policy makers, researchers, and implementer…

  • Strengthening pathogen genomic surveillance for health emergencies

    Open AccessOluwatosin Akande, Lisa L Carter et al.ARTICLEFrontiers in Public Health2023

    The onset of the COVID-19 pandemic triggered a rapid scale-up in the use of genomic surveillance as a pandemic preparedness and response tool. As a result, the number of countries with in-country SARS-CoV-2 genomic sequencing capability increased by 40% from February 2021 to July 2022. The Global Genomic Surveillance Strategy for Pathogens with Pandemic and Epidemic Potential 2022–2032 was launched by the World Health Organization (WHO) in March …

  • Evaluating diagnostic tests during outbreaks

    Open AccessCamille Escadafal, Rossella Baldan et al.ARTICLEBMJ Global Health2023

  • Diagnostic performance of four lateral flow immunoassays for Covid-19 antibodies in Peruvian population

    Open AccessRodrigo Calderon-Flores, Guillermo Caceres-Cardenas et al.ARTICLEPLOS Global Public Health2023

    Serological assays have been used in seroprevalence studies to inform the dynamics of COVID-19. Lateral flow immunoassay (LFIA) tests are a very practical technology to use for this objective; however, one of their challenges may be variable diagnostic performance. Given the numerous available LFIA tests, evaluation of their accuracy is critical before real-world implementation. We performed a retrospective diagnostic evaluation study to independ…

  • Two-test algorithms for infectious disease diagnosis

    Open AccessSunil Pokharel, Lisa J White et al.ARTICLEPLOS Global Public Health2022

    Diagnostic assays for various infectious diseases, including COVID-19, have been challenged for their utility as standalone point-of-care diagnostic tests due to suboptimal accuracy, complexity, high cost or long turnaround times for results. It is therefore critical to optimise their use to meet the needs of users. We used a simulation approach to estimate diagnostic outcomes, number of tests required and average turnaround time of using two-tes…